Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Sponsor: Eli Lilly and Company
Summary
The purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
Official title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3561774 (Solbinsiran) in Adults With Severe Hypertriglyceridemia
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-12-08
Completion Date
2027-08
Last Updated
2026-03-20
Healthy Volunteers
No
Conditions
Interventions
Solbinsiran
Administered SC
Placebo
Administered SC
Locations (40)
Axsendo Clinical Research - Peak Heart & Vascular - Phoenix
Phoenix, Arizona, United States
Synexus Clinical Research US, Inc./Orange Grove Family Practice
Tucson, Arizona, United States
National Heart Institute
Beverly Hills, California, United States
Ark Clinical Research
Long Beach, California, United States
Catalina Research Institute, LLC
Montclair, California, United States
Valley Clinical Trials, Inc.
Northridge, California, United States
CMR of Greater New Haven, LLC
Hamden, Connecticut, United States
Northeast Research Institute - Downtown Office
Jacksonville, Florida, United States
Novera Clinical Research
Miami, Florida, United States
Inpatient Research Clinic
Miami Lakes, Florida, United States
Clinical Site Partners, LLC dba Flourish Research
Winter Park, Florida, United States
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois, United States
Investigators Research Group
Brownsburg, Indiana, United States
Saint Elizabeth Healthcare - Saint Elizabeth Covington Hospital
Covington, Kentucky, United States
Flourish Research - Bowie
Bowie, Maryland, United States
University of Massachusetts Chan Medical School
Worcester, Massachusetts, United States
AB Clinical Trials
Las Vegas, Nevada, United States
Clinical Research of Philadelphia
Pennington, New Jersey, United States
Weill Cornell Medical College
New York, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Cardiovascular Specialists of Willowbrook
Houston, Texas, United States
Southern Endocrinology Associates
Mesquite, Texas, United States
American Research Corporation at Texas Liver Institute
San Antonio, Texas, United States
Endeavor Clinical Trials
San Antonio, Texas, United States
Stroobants Cardiovascular Center
Lynchburg, Virginia, United States
TPMG (Tidewater Physicians Multispecialty Group) Clinical Research
Newport News, Virginia, United States
Carilion Clinic
Roanoke, Virginia, United States
Eastside Research Associates
Redmond, Washington, United States
UW Medicine Diabetes Institute
Seattle, Washington, United States
Ecogene-21
Chicoutimi, Canada
C.I.C. Mauricie inc.
Trois-Rivières, Canada
ARC Biosystems
Vancouver, Canada
Peking University Third Hospital
Beijing, China
Sichuan Provincial People's Hospital
Chengdu, China
Guangdong Provincial People's Hospital
Guangzhou, China
The First Affiliated Hospital of Henan University of Science &Technology
Luoyang Shi, China
Zhongshan Hospital,Fudan University
Shanghai, China
The Affiliated Hospital of Xuzhou Medical College
Xuzhou, China
The Institute of Medical Science, Asahi Life Foundation
Chūōku, Japan
Takai Internal Medicine Clinic
Kamakura-shi, Japan